Screening the pandemic response box identified benzimidazole carbamates, Olorofim and ravuconazole as promising drug candidates for the treatment of eumycetoma W Lim, B Nyuykonge, K Eadie, M Konings, J Smeets, A Fahal, A Bonifaz, ... PLoS Neglected Tropical Diseases 16 (2), e0010159, 2022 | 25 | 2022 |
Diagnostic implications of mycetoma derived from Madurella pseudomycetomatis isolates from Mexico B Nyuykonge, CHW Klaassen, WHA Zandijk, GS de Hoog, SA Ahmed, ... Journal of the European Academy of Dermatology and Venereology 34 (8), 1828-1834, 2020 | 17 | 2020 |
The development of a novel diagnostic PCR for Madurella mycetomatis using a comparative genome approach W Lim, E Siddig, K Eadie, B Nyuykonge, S Ahmed, A Fahal, A Verbon, ... PLOS Neglected Tropical Diseases 14 (12), e0008897, 2020 | 14 | 2020 |
Mycetoma caused by Microascus gracilis: a novel agent of human eumycetoma in Sudan NA Mhmoud, EE Siddig, B Nyuykonge, SM Bakhiet, WWJ van de Sande, ... Transactions of The Royal Society of Tropical Medicine and Hygiene 115 (4 …, 2021 | 13 | 2021 |
Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole B Nyuykonge, W Lim, L van Amelsvoort, A Bonifaz, A Fahal, H Badali, ... Mycoses 65 (6), 650-655, 2022 | 12 | 2022 |
Human actinomycetoma caused by Actinomadura mexicana in Sudan: the first report EE Siddig, B Nyuykonge, MT Ahmed, R Hassan, ESA Saad, NA Mhmoud, ... Transactions of The Royal Society of Tropical Medicine and Hygiene 115 (4 …, 2021 | 9 | 2021 |
A Short-Tandem-Repeat Assay (MmySTR) for Studying Genetic Variation in Madurella mycetomatis B Nyuykonge, K Eadie, WHA Zandijk, SA Ahmed, M Desnos-Ollivier, ... Journal of Clinical Microbiology 59 (3), 10.1128/jcm. 02331-20, 2021 | 8 | 2021 |
Epidemiological cut‐off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetoma B Nyuykonge, EE Siddig, NA Mhmoud, BA Nyaoke, EE Zijlstra, A Verbon, ... Mycoses 65 (12), 1170-1178, 2022 | 7 | 2022 |
Comparing the performance of the common used eumycetoma diagnostic tests EE Siddig, B Nyuykonge, NA Mhmoud, OB Abdallah, MEN Bahar, ... Mycoses 66 (5), 420-429, 2023 | 6 | 2023 |
Comparison of Disc Diffusion, Etest, and a Modified CLSI Broth Microdilution Method for In Vitro Susceptibility Testing of Itraconazole, Posaconazole, and Voriconazole … B Nyuykonge, L van Amelsvoort, K Eadie, AH Fahal, A Verbon, ... Antimicrobial Agents and Chemotherapy 65 (9), 10.1128/aac. 00433-21, 2021 | 6 | 2021 |
Madurella mycetomatis grains within a eumycetoma lesion are clonal B Nyuykonge, EE Siddig, M Konings, S Bakhiet, A Verbon, ... Medical Mycology 60 (7), myac051, 2022 | 4 | 2022 |
Pyomelanin secretion in Madurella mycetomatis interferes with spectrophotometric endpoint reading using the Sensititre YeastOne alamarBlue assay but not with visual endpoint … B Nyuykonge, PD Croughs, AH Fahal, A Verbon, WWJ van de Sande Antimicrobial Agents and Chemotherapy 64 (1), 10.1128/aac. 01532-19, 2019 | 4 | 2019 |
Staphylococcus aureus causing primary foot botryomycosis mimicking actinomycetoma: a case report from Sudan EE Siddig, B Nyuykonge, OELH Bakheit, OB Hassan, ES Ahmed, ... International Journal of Infectious Diseases 124, 224-226, 2022 | 3 | 2022 |
Wako β‐D‐glucan assay can be used to measure serum β‐D‐glucan in Sudanese patients to aid with diagnosis of eumycetoma caused by Madurella mycetomatis B Nyuykonge, E Siddig, NA Mhmoud, S Bakhiet, E Zijlstra, A Verbon, ... Journal of the European Academy of Dermatology and Venereology 37 (4), 783-786, 2023 | 2 | 2023 |
The combination of manogepix and itraconazole is synergistic and inhibits the growth of Madurella mycetomatis in vitro but not in vivo M Konings, K Eadie, N Strepis, B Nyuykonge, AH Fahal, A Verbon, ... Medical Mycology 61 (11), myad118, 2023 | 1 | 2023 |
Using (1,3)‐β‐D‐glucan concentrations in serum to monitor the response of azole therapy in patients with eumycetoma caused by Madurella mycetomatis B Nyuykonge, EE Siddig, BA Nyaoke, EE Zijlstra, A Verbon, SM Bakhiet, ... Mycoses 67 (1), e13664, 2024 | | 2024 |
Clinical evaluation of the performance of the most commonly used eumycetoma diagnostic tests using sequencing of the internally transcribed spacer region as the golden standard E Siddig, B Nyuykonge, N Mhmoud, O Abdallah, M Bahar, E Ahmed, ... Medical Mycology 60 (S1), 263, 2022 | | 2022 |
S4. 5d Comparing the diagnostic performance of the commonly used eumycetoma diagnostic tests using sequencing of the internally transcribed spacer region as the gold standard E Siddig, B Nyuykonge, N Mhmoud, O Abdallah, M Bahar, E Ahmed, ... Medical Mycology 60 (Supplement_1), myac072S45d, 2022 | | 2022 |
S4.5c Using serum beta-glucan measurements and sequencing of the Madurella mycetomatis azole target gene to predict therapeutic outcome during azole … B Nyuykonge, E Siddig, N Mhmoud, B Nyaoke, E Zijlstra, A Verbon, ... Medical Mycology 60 (Supplement_1), myac072S45c, 2022 | | 2022 |
Correction for Nyuykonge et al., “Pyomelanin Secretion in Madurella mycetomatis Interferes with Spectrophotometric Endpoint Reading Using the Sensititre … B Nyuykonge, PD Croughs, AH Fahal, A Verbon, WWJ van de Sande Antimicrobial Agents and Chemotherapy 64 (11), 10.1128/aac. 01848-20, 2020 | | 2020 |